#None #Class Action #ClaimsFiler #Hims & Hers

Hims & Hers Health Investor Alert

In a recent announcement, ClaimsFiler, a prominent shareholder information service, has issued a critical reminder for investors in Hims & Hers Health, Inc. (NYSE: HIMS). Those who incurred losses exceeding $100,000 by investing in the company's securities between August 4, 2025, and July 29, 2026, should take note of the approaching deadline to file for lead plaintiff status in a significant class action lawsuit against the firm.

Important Deadlines and Filing Information

Investors have until November 2, 2026, to submit their lead plaintiff applications in what is known as the Velanki v. Hims & Hers Health, Inc. et al. case, currently pending in the United States District Court for the Northern District of California. This lawsuit has arisen due to allegations alleging that Hims & Hers and certain executives did not disclose essential information during the class period, violating federal securities laws.

Accusations Against Hims & Hers Health

On July 29, 2026, the Federal Trade Commission (FTC) made headlines when it revealed a lawsuit against Hims & Hers Health. The FTC claimed that the telehealth provider had improperly shared sensitive health information with third-party advertising firms, despite assurances to consumers regarding privacy. Furthermore, the lawsuit accused the company of misleading customers about billing and cancellation procedures. These claims suggest that consumers were charged for prescriptions almost immediately after submitting an intake form while being led to believe they would consult with a medical provider first.

In light of these accusations, Hims & Hers Health faced a significant downturn in its stock price. On the same day the FTC made its announcement, shares plummeted by $4.32, equivalent to a 14.73% decrease, closing at $25.00. This sharp decline was attributed to unusually high trading volumes, underscoring the market's reaction to the negative news.

How to Get Involved

ClaimsFiler encourages affected investors to gather relevant documentation and visit ClaimsFiler's dedicated page for further information and registration regarding the class action lawsuit. They also provide a toll-free number (833-538-3604) for investors to discuss their potential legal options with attorneys from Kahn Swick & Foti, LLC, who are accessible for consultations and case evaluations.

The Role of ClaimsFiler

Established with the commitment to assist retail investors, ClaimsFiler serves as an invaluable resource for those looking to recover their investments from securities class action settlements. They offer a range of services, including the ability to register for timely notifications about relevant cases, and facilitated claim submissions. Their mission is clear: to help investors navigate the complexities of securities litigation effectively. For additional resources and information, visiting ClaimsFiler's website is highly recommended.

In conclusion, investors holding shares of Hims & Hers Health should pay close attention to this legal action and consider their rights and options as the deadline approaches. Ensuring timely participation in the class action may significantly impact potential recovery from the alleged misconduct in question.